| Detected | Trial | Change |
|---|---|---|
| 2026-07-31 | NCT04268524 Randomised Clinical Trial in Treatment Modalities for Cutaneous Leishmaniasis Caused by… |
Trial completed |
| 2026-07-31 | NCT04268524 Randomised Clinical Trial in Treatment Modalities for Cutaneous Leishmaniasis Caused by… |
Enrollment reduced: 832 -> 645 participants |
| 2026-07-31 | NCT04268524 Randomised Clinical Trial in Treatment Modalities for Cutaneous Leishmaniasis Caused by… |
date change Primary completion pushed: 2025-12-31 -> 2026-06-19 |
| 2026-07-31 | NCT04268524 Randomised Clinical Trial in Treatment Modalities for Cutaneous Leishmaniasis Caused by… |
date change Completion pushed: 2026-01-31 -> 2026-06-19 |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Not specified | |||
| NCT07659002 | Polyvalent Antivenom (Premium-PANAF) for Snakebite Envenoming in Ethiopia | Snake Envenomation | Recruiting |